These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31276688)

  • 21. TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells.
    Sagredo AI; Sagredo EA; Cappelli C; Báez P; Andaur RE; Blanco C; Tapia JC; Echeverría C; Cerda O; Stutzin A; Simon F; Marcelain K; Armisén R
    Mol Oncol; 2018 Feb; 12(2):151-165. PubMed ID: 28614631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of EphA1 protein in prostate cancers correlates with high Gleason score.
    Peng L; Wang H; Dong Y; Ma J; Wen J; Wu J; Wang X; Zhou X; Wang J
    Int J Clin Exp Pathol; 2013; 6(9):1854-60. PubMed ID: 24040450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircLMTK2 acts as a tumor suppressor in prostate cancer via regulating the expression of microRNA-183.
    Jin C; Zhao W; Zhang Z; Liu W
    Life Sci; 2020 Jan; 241():117097. PubMed ID: 31760099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of drs mRNA in human prostate carcinomas.
    Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H
    Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue.
    Bründl J; Wallinger S; Breyer J; Weber F; Evert M; Georgopoulos NT; Rosenhammer B; Burger M; Otto W; Rubenwolf P
    BMC Urol; 2018 Sep; 18(1):75. PubMed ID: 30176851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and β-catenin and enhances invasion in nasopharyngeal carcinoma cells.
    Yip WK; Seow HF
    Cancer Lett; 2012 May; 318(2):162-72. PubMed ID: 22182447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
    Nalla AK; Estes N; Patel J; Rao JS
    Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulated Krüppel‑like factor 4 expression is associated with the aggressiveness of prostate cancer.
    Zhang N; Su P; Li X; Xi J; Li X; Xu L
    Oncol Rep; 2019 Mar; 41(3):1789-1796. PubMed ID: 30747213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
    Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
    Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
    Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
    Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
    J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
    Lee J; Ju J; Park S; Hong SJ; Yoon S
    Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.
    Hoyne G; Rudnicka C; Sang QX; Roycik M; Howarth S; Leedman P; Schlaich M; Candy P; Matthews V
    BMC Cancer; 2016 Feb; 16():151. PubMed ID: 26912236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARI, a novel target gene of glucocorticoid receptor, plays an important role in dexamethasone-mediated killing of B lymphoma cells.
    Huang Y; Zhou J; Huang Y; He J; Wang Y; Yang C; Liu D; Zhang L; He F
    Cancer Lett; 2016 Apr; 373(1):57-66. PubMed ID: 26808579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.
    Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J
    Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased SARI expression predicts poor prognosis of Chinese patients with non-small cell lung cancer.
    Zhou RJ; Shi Z; Zhou K; Wang HD; Zhang GQ; Li XT; Xu JP
    Int J Clin Exp Pathol; 2013; 6(10):2056-63. PubMed ID: 24133583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.